COSMOS Pharmaceutical Corporation (CSMYF)
USD 46.06
(-0.22%)
USD 46.06
(-0.22%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 86.17 Billion JPY | 11.22% |
| 2023 | 77.47 Billion JPY | 16.75% |
| 2022 | 66.36 Billion JPY | 9.6% |
| 2021 | 60.54 Billion JPY | 13.05% |
| 2020 | 53.56 Billion JPY | 0.51% |
| 2019 | 53.28 Billion JPY | 9.31% |
| 2018 | 48.74 Billion JPY | 21.76% |
| 2017 | 40.03 Billion JPY | 4.74% |
| 2016 | 38.22 Billion JPY | 9.65% |
| 2015 | 34.86 Billion JPY | 11.52% |
| 2014 | 31.26 Billion JPY | 13.54% |
| 2013 | 27.53 Billion JPY | 13.77% |
| 2012 | 24.19 Billion JPY | 23.15% |
| 2011 | 19.65 Billion JPY | 1.82% |
| 2010 | 19.29 Billion JPY | 17.44% |
| 2009 | 16.43 Billion JPY | 11.38% |
| 2008 | 14.75 Billion JPY | 10.24% |
| 2007 | 13.38 Billion JPY | 14.52% |
| 2006 | 11.68 Billion JPY | 44.05% |
| 2005 | 8.11 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 82.51 Billion JPY | -3.29% |
| 2024 Q4 | 86.17 Billion JPY | 4.44% |
| 2024 FY | 86.17 Billion JPY | 11.22% |
| 2024 Q2 | 85.31 Billion JPY | 6.87% |
| 2024 Q1 | 79.82 Billion JPY | 3.03% |
| 2023 Q3 | 70.13 Billion JPY | -1.88% |
| 2023 FY | 77.47 Billion JPY | 16.75% |
| 2023 Q4 | 77.47 Billion JPY | 10.47% |
| 2023 Q2 | 71.47 Billion JPY | 10.13% |
| 2023 Q1 | 64.9 Billion JPY | -2.2% |
| 2022 Q4 | 66.36 Billion JPY | 3.24% |
| 2022 Q3 | 64.28 Billion JPY | -0.11% |
| 2022 FY | 66.36 Billion JPY | 9.6% |
| 2022 Q1 | 60.25 Billion JPY | -0.48% |
| 2022 Q2 | 64.35 Billion JPY | 6.8% |
| 2021 Q4 | 60.54 Billion JPY | 8.26% |
| 2021 Q1 | 53.71 Billion JPY | 0.29% |
| 2021 Q3 | 55.93 Billion JPY | -1.27% |
| 2021 Q2 | 56.64 Billion JPY | 5.46% |
| 2021 FY | 60.54 Billion JPY | 13.05% |
| 2020 Q4 | 53.56 Billion JPY | 7.6% |
| 2020 FY | 53.56 Billion JPY | 0.51% |
| 2020 Q1 | 51.5 Billion JPY | -3.35% |
| 2020 Q2 | 52.98 Billion JPY | 2.88% |
| 2020 Q3 | 49.77 Billion JPY | -6.06% |
| 2019 Q1 | 47.81 Billion JPY | -1.93% |
| 2019 Q4 | 53.28 Billion JPY | 1.59% |
| 2019 FY | 53.28 Billion JPY | 9.31% |
| 2019 Q2 | 51.81 Billion JPY | 8.38% |
| 2019 Q3 | 52.45 Billion JPY | 1.23% |
| 2018 FY | 48.74 Billion JPY | 21.76% |
| 2018 Q2 | 43.79 Billion JPY | 9.23% |
| 2018 Q1 | 40.09 Billion JPY | 0.14% |
| 2018 Q4 | 48.74 Billion JPY | 10.52% |
| 2018 Q3 | 44.1 Billion JPY | 0.71% |
| 2017 Q4 | 40.03 Billion JPY | 3.4% |
| 2017 FY | 40.03 Billion JPY | 4.74% |
| 2017 Q3 | 38.72 Billion JPY | -2.34% |
| 2017 Q2 | 39.65 Billion JPY | 6.37% |
| 2017 Q1 | 37.27 Billion JPY | -2.48% |
| 2016 Q1 | 34.89 Billion JPY | 0.08% |
| 2016 FY | 38.22 Billion JPY | 9.65% |
| 2016 Q4 | 38.22 Billion JPY | 3.78% |
| 2016 Q3 | 36.83 Billion JPY | -2.5% |
| 2016 Q2 | 37.77 Billion JPY | 8.28% |
| 2015 Q2 | 33.06 Billion JPY | 7.68% |
| 2015 Q3 | 35.54 Billion JPY | 7.52% |
| 2015 Q4 | 34.86 Billion JPY | -1.93% |
| 2015 FY | 34.86 Billion JPY | 11.52% |
| 2015 Q1 | 30.7 Billion JPY | -1.78% |
| 2014 Q2 | 29.98 Billion JPY | 11.89% |
| 2014 Q3 | 30.78 Billion JPY | 2.67% |
| 2014 FY | 31.26 Billion JPY | 13.54% |
| 2014 Q1 | 26.79 Billion JPY | -2.66% |
| 2014 Q4 | 31.26 Billion JPY | 1.54% |
| 2013 Q4 | 27.53 Billion JPY | 4.04% |
| 2013 Q2 | 28.72 Billion JPY | 22.28% |
| 2013 FY | 27.53 Billion JPY | 13.77% |
| 2013 Q1 | 23.48 Billion JPY | -2.94% |
| 2013 Q3 | 26.46 Billion JPY | -7.86% |
| 2012 FY | 24.19 Billion JPY | 23.15% |
| 2012 Q3 | 23.18 Billion JPY | -1.19% |
| 2012 Q2 | 23.45 Billion JPY | 16.71% |
| 2012 Q4 | 24.19 Billion JPY | 4.39% |
| 2012 Q1 | 20.1 Billion JPY | 2.3% |
| 2011 Q2 | 19.44 Billion JPY | 5.76% |
| 2011 FY | 19.65 Billion JPY | 1.82% |
| 2011 Q4 | 19.65 Billion JPY | 2.94% |
| 2011 Q3 | 19.08 Billion JPY | -1.84% |
| 2011 Q1 | 18.38 Billion JPY | -4.73% |
| 2010 Q3 | 19.4 Billion JPY | 0.0% |
| 2010 FY | 19.29 Billion JPY | 17.44% |
| 2010 Q4 | 19.29 Billion JPY | -0.54% |
| 2009 Q3 | 15.9 Billion JPY | 4.71% |
| 2009 FY | 16.43 Billion JPY | 11.38% |
| 2009 Q2 | 15.18 Billion JPY | 0.0% |
| 2009 Q4 | 16.43 Billion JPY | 3.32% |
| 2008 FY | 14.75 Billion JPY | 10.24% |
| 2007 FY | 13.38 Billion JPY | 14.52% |
| 2006 FY | 11.68 Billion JPY | 44.05% |
| 2005 FY | 8.11 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 129.52 Million USD | -66431.852% |
| Café Serendipity Holdings, Inc. | - USD | -Infinity% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 0.64 USD | -13464531249900.0% |
| HealthWarehouse.com, Inc. | 509.11 Thousand USD | -16925905.075% |
| LIGAND PHARMACEUTICAL INC | 23.96 Million USD | -359418.545% |
| MedGen, Inc. | - USD | -Infinity% |
| Omni Health, Inc. | 380.1 Thousand USD | -22670502.38% |
| Oxford Investments Holdings Inc. | 124.35 Thousand USD | -69297538.96% |
| Pineapple, Inc. | 4710.00 USD | -1829575271.55% |
| ScripsAmerica, Inc. | 735.76 Thousand USD | -11711959.454% |